https://ijm.tums.ac.ir/index.php/ijm/issue/feed Iranian Journal of Microbiology 2024-12-21T09:33:33+0330 Mohammad Mehdi Feizabadi, PhD ijm@tums.ac.ir Open Journal Systems https://ijm.tums.ac.ir/index.php/ijm/article/view/5167 World antimicrobial resistance (AMR) awareness week 2024-12-21T09:32:25+0330 Mohammad Mehdi Feizabadi feizabadimm@gmail.com <p>Editorial Note</p> <p>Mohammad Medhdi Feizabadi</p> <p>Editor</p> <p>Iranian Journal of Microbiology</p> <p>On the occasion of World Antimicrobial Resistance (AMR) Awareness Week, November 2024, we witnessed a lot of events throughout our country, Iran. Many different specialists throughout the country debated on the current situation, however, no one can predict the future outlook of this ongoing issue. The health policy makers try to find the right solutions for combating the drug-resistant superbugs but they should not ignore Microbiology principles. Carbapenem-resistant <em>Klbesiella pneumoniae</em> infections are definitely the main causes of morbidity and mortality in the Iranian Hospitals. In the current issue of this Journal, Dr. Solgi and his colleagues have raised an important and critical point: New Delhi metallo-beta-lactamase (NDM-MBL). Unfortunately, the number of cases infected with ceftazidime/avibactam-resistant Gram-negative bacteria has increased due to NDM-MBL production (Nearly 87% of <em>K. pneumoniae</em> clinical isolates in Isfahan). Therefore, our country resources are wasted with the current official protocol for administration of ceftazidime/avibactam, despite knowing that NDM-MBL producers are dominant. Physicians should be aware of the current situation of MBL strains in Iran, which is attainable through reviewing works published by Microbiologists in different provinces of Iran.</p> <p>&nbsp;</p> 2024-12-08T09:50:40+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/5161 Experimental prescription, rising resistance: the alarming misuse of ceftazidime-avibactam in healthcare systems 2024-12-21T09:32:28+0330 Mojtaba Akbari akbari.epi@gmail.com Christian G Giske christian.giske@regionstockholm.se Hamid Solgi hamid.solgi@gmail.com <p>No abstract</p> 2024-12-08T09:55:14+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4673 Systematic review and meta-analysis of colistin plus meropenem therapy for the treatment of nosocomial pneumonia 2024-12-21T09:32:31+0330 Hazhir Moradi moradi.hazhir@gmail.com Zahra Sadat Sajadi-Javan bestgoal.zs73@yahoo.com Sarah Mousavi s.mousavi@pharm.mui.ac.ir Soodabeh Rostami srostami1876@gmail.com Bita Moradi Khaniabadi bitamoradi86@gmail.com <p><strong>Background and Objectives:</strong> Nosocomial pneumonia caused by multidrug-resistant gram-negative bacteria presents a significant challenge for healthcare systems, as there are limited effective treatments available. This systematic review and meta-analysis aim to investigate the outcomes of colistin plus meropenem combination therapy on nosocomial pneumonia.<br><strong>Materials and Methods:</strong> An exhaustive search of PubMed, Scopus, Web of Science (WOS), and Embase databases was conducted, resulting in the extraction of 5 studies for qualitative assessment and meta-analysis. The study sample included 991 patients admitted with nosocomial pneumonia. The outcomes evaluated were clinical improvement, microbiological response, mortality, Sequential Organ Failure Assessment (SOFA) score, Acute Physiology and Chronic Health Evaluation (APACHE II) score, Charlson Comorbidity Index (CCI), Clinical Pulmonary Infection Score (CPIS), C-reactive protein (CRP) levels, procalcitonin (PCT) levels, and intensive care unit (ICU) duration.<br><strong>Results:</strong> The results demonstrated that colistin plus meropenem combination therapy significantly improved clinical outcomes (OR = 1.37, 95% CI = 1.04-1.81, p = 0.027), reduced SOFA scores (OR = -0.28, 95% CI = -0.44 to -0.11, p = 0.001), and increased CCI scores (OR = 0.16, 95% CI = 0.02-0.29, p = 0.021) compared to other medications. However, other evaluated parameters did not show significant differences.<br><strong>Conclusion:</strong> This meta-analysis indicates that colistin-meropenem combination therapy is superior to other colistin-based treatments for nosocomial pneumonia in terms of clinical improvement, SOFA score reduction, and CCI score increase. Nevertheless, other variables assessed did not exhibit remarkable differences between the treatment regimens.</p> 2024-12-08T09:57:01+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4891 Evaluating the in vitro activity of cefoperazone-sulbactam against Gram negative pathogens in blood stream infections using automated systems 2024-12-21T09:32:35+0330 Uksim Qadri uksimqadri6@gmail.com Sofiya Zaffar sofiazaffar@gmail.com Saleem Javaid Wani mail_gazi@yahoo.co.in Shugufta Roohi drshaguftar@gmail.com Munazah Aman drmunaza27aman@gmail.com Sabah Bhat sabahbhat418@gmail.com Umaya Majid umayamajid@gmail.com <p><strong>Background and Objectives:</strong> The incidence of multidrug-resistant, Gram-negative organisms, isolated as the etiological agents of infections is ascending. The advent of novel antibiotics poses significant challenges, necessitating the optimization and utilization of extant antimicrobial agents. Cefoperazone, a third-generation cephalosporin and β-lactam antimicrobial, when combined with sulbactam, an irreversible β-lactamase inhibitor, mitigates the vulnerability of cefoperazone to β-lactamase-producing organisms. Nonetheless, regional data on the susceptibility patterns for this pharmacological combination remains scarce. The primary objective of this investigation was to assess the efficacy of the cefoperazone-sulbactam combination against prevalent Gram-negative bacteria isolated from blood cultures.<br><strong>Materials and Methods:</strong> A total of 700 Gram-negative isolates, comprising <em>Escherichia coli, Klebsiella pneumoniae, Acinetobacter</em> species, and <em>Pseudomonas aeruginosa,</em> were procured using the BacT/Alert 3D system. The identification and susceptibility testing for cefoperazone-sulbactam were performed using the VITEK Compact ID and AST system. Comparative analysis was conducted against other tested antibiotics.<br><strong>Results:</strong> The study revealed that cefoperazone-sulbactam exhibited commendable <em>in-vitro</em> activity against Gram-negative pathogens isolated from blood, surpassed only by colistin and tigecycline.<br><strong>Conclusion:</strong> Cefoperazone-sulbactam demonstrates robust activity against the most frequently encountered clinical pathogens, suggesting its potential as an efficacious therapeutic agent. The findings underscore the imperative for ongoing surveillance of resistance patterns and trends among commonly used antimicrobials.</p> 2024-12-08T09:58:33+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4964 Lessons from an 11-year retrospective cohort study of Escherichi coli causing UTI in Imam Hospital Ardabil, Iran 2024-12-21T09:32:39+0330 Pegah Shakib shakib.pegah@yahoo.com Mohsen Arzanlou Mohsen.Arzanlou@yahoo.com Pouria Sobhi Pouria.Sobhi@yahoo.com Mehdi Mojebi Mehdi.Mojebi@yahoo.com Mohammad Bahrami Mohammad.Bahrami@yahoo.com Faraz Mahdizadeh Faraz.Mahdizadeh@yahoo.com Leyla Asadi Leyla.Asadi@yahoo.com Masoud Amanzadeh Masoud.Amanzadeh@yahoo.com Alireza Mohammadnia Alireza.Mohammadnia@yahoo.com Farzad Khademi Farzad.Khademi@yahoo.com Rashid Ramazanzadeh atrop_t51@yahoo.com <p><strong>Background and Objectives:</strong> The global problem of urinary tract infections (UTIs) caused by antibiotic-resistant bacteria is due to limited treatment options. This study aimed to examine the prevalence, etiology, and management implications of <em>Escherichi coli</em> causing UTI at Imam Hospital Ardabil, Iran.<br><strong>Materials and Methods:</strong> 2340 samples of retrospective data on <em>E. coli</em> causing UTIs were collected at Imam Hospital in Ardabil, Iran, spanning from 2012 to 2022. The samples were cultured and isolated, and their antibiotic susceptibility was determined using standard laboratory methods and data were then organized and systematically categorized using Python.<br><strong>Results:</strong> It was found that the lowest level of resistance was related to nitrofurantoin, followed by imipenem. In 2018, the number of<em> E. coli</em> patients resistant to trimethoprim was the highest. Cephalexin and ciprofloxacin trends indicate the reduction of the line during this retrospective period. There was a significant correlation between wards and some antibiotics like Cefepime, Cefotaxime, Ceftazidime, and Trimethoprim (P-Value &lt;0.05).<br><strong>Conclusion:</strong> Significant correlations were identified between specific hospital wards and resistance to antibiotics. These findings underscore the need for continuous surveillance and tailored antibiotic stewardship programs to combat the rising trend of antibiotic resistance.</p> 2024-12-08T10:00:03+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4892 High prevalence of antimicrobial resistance genes in multidrug-resistant-ESBLs-producing Klebsiella pneumoniae post-COVID-19 pandemic 2024-12-21T09:32:42+0330 Golnar Rahimzadeh rahimzadehgolnar@yahoo.com Shaghayegh Rezai rezai.shaghayegh1992@gmail.com Ghazal Abbasi ghazal.abbasi.sh@gmail.com Saman Soleimanpour niloofarrezaee.nr71@gmail.com Reza Valadan valadan.reza@gmail.com Laleh Vahedi lalevahedi@gmail.com Somayeh Sheidaei s.sheidaie2015@yahoo.com Faezeh Sadat Movahedi f.movahedi69@gmail.com Raha Rezai grahimzadeh@mazums.ac.ir Mohammad Sadegh Rezai rezai@mazums.ac.ir <p><strong>Background and Objectives:</strong> <em>Klebsiella pneumoniae</em> is a common pathogen associated with healthcare-related infections. It is particularly notable for its ability to develop resistance to multiple antibiotics, making treatment challenging. During the COVID-19 pandemic, increased antibiotic use to manage critically ill patients was contributed to the rise of multidrug-resistant <em>Klebsiella pneumoniae.</em> This study evaluated the antibiotic resistance patterns of multidrug-resistant, ESBL-producing <em>Klebsiella pneumoniae</em> in northern Iran after the COVID-19 pandemic.<br><strong>Materials and Methods:</strong> This cross-sectional study was conducted between September 2022 and October 2023. Clinical samples were collected from patients with nosocomial infections at hospitals in Sari. This study included 114 multidrug-resistant ESBLs-producing <em>Klebsiella pneumoniae</em> isolates. Antimicrobial susceptibility was assessed using broth macro-dilution, and resistance genes were detected by multiplex PCR.<br><strong>Results:</strong> Gentamicin, ampicillin-sulbactam, co-amoxiclav, and ceftazidime displayed the lowest activity against multidrug-resistant <em>Klebsiella pneumoniae</em>. In contrast, piperacillin-tazobactam showed the highest activity. The prevalence of resistance genes was as follows: <em>bla</em><sub>TEM</sub> (99.12%), <em>bla</em><sub>SHV</sub> (74.56%), <em>bla</em><sub>CTX</sub> (88.60%), <em>bla</em><sub>IMP</sub> (64.04%), <em>acrA -B</em> (92.98%), and <em>OqXA -B</em> (67.54%).<br><strong>Conclusion:</strong> This study identified over 50% of antibiotic-resistance genes. Over half of multidrug-resistant <em>Klebsiella pneumoniae</em> isolates showed resistance to antibiotics except piperacillin-tazobactam, which is recommended for treating multidrug-resistant <em>Klebsiella pneumoniae</em> infections.</p> 2024-12-08T10:02:46+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4679 Frequency and antibiotic resistance pattern of Salmonella spp. isolated from traditional dairies and raw milks collected in Yazd province, Iran 2024-12-21T09:32:59+0330 Raziyeh Barzegar-Bafrouei RaziyehBarzegar@yahoo.com Bahador Hajimohammadi b.hajimohammadi@gmail.com Hengameh Zandi hengameh_zandi@yahoo.com Gilda Eslami eslami_g2000@yahoo.com Hossein Fallahzadeh hofaab@yahoo.com <p><strong>Background and Objectives:</strong> Salmonellosis is among the most common food-born infections, caused by <em>Salmonella</em> spp. bacteria. Present study has investigated the frequency and antibiotic resistance pattern of <em>Salmonella</em> spp. isolated from traditional dairy products and raw milk supplied in Yazd, Iran.<br><strong>Materials and Methods:</strong> In a cross-sectional study, 350 samples of raw milk and traditional dairy products were randomly collected from July to September 2018. Following culturing the samples, isolates went through biochemical tests for phenotypic identification. Results were confirmed through PCR technique by targeting <em>invA</em> gene. Antimicrobial susceptibility test was conducted by means of disk diffusion method.<br><strong>Results:</strong> The rate of contamination with <em>Salmonella</em> bacteria was 6.57% in all samples. The PCR assay of all isolates showed that 23 isolates (100%) carried the <em>invA</em> gene. No significant association between the frequency of <em>salmonella</em> spp. and types of dairy and their origin was reported (P&gt;0.05). The highest antibiotic resistance rate among the isolates belonged to tetracycline (34.8%) and the highest sensitivity was seen to imipenem, cefepime, and cefotaxime (each 91.3%).<br><strong>Conclusion:</strong> According to our results there has been a rise in multiple drug resistance and contamination rate in traditional dairy products in Yazd province.</p> 2024-12-08T10:04:15+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4746 Anti-invasion activities of heat-killed lactic acid bacteria isolates against Salmonella enterica serovar Typhimurium 2024-12-21T09:33:03+0330 Anis Syahirah Saifor Adzuan anissyahirah.assa@gmail.com Sharifah Aminah Syed Mohamad sharifah459@uitm.edu.my Rashidah Iberahim rashidah@uitm.edu.my Noor Nadia Syahira Mohd Kamal naddsyahira25@gmail.com Nurliana Abd Mutalib nurliana.abd.mutalib@outlook.com Nur Intan Hasbullah intan154@uitm.edu.my Muneer Alsaydi smuneer006@gmail.com Nor'aishah Hasan aishahnh@uitm.edu.my Low Kheng Oon khengoon@nibm.my Olaide Olawunmi Ajibola olaideajibola@gmail.com Rozila Alias rozila@unisel.edu.my Maimunah Mustakim maimunah@uitm.edu.my Azlin Sham Rambely azlinsham@uitm.edu.my Emida Mohamed emida894@uitm.edu.my Mohammad Reza Pourmand mpourmand@tums.ac.ir <p><strong>Background and Objectives:</strong> The most common cause of severe foodborne salmonellosis is <em>S.</em> Typhimurium. Its interaction with intestinal epithelial cells is little known. Lactic acid bacteria (LAB) were recognized as a prominent probiotic gastrointestinal microbiota of humans and animals that confer health-promoting and protective effects. This study aims to determine the anti-invasion and antibacterial effects of heat-killed LAB (HK-LAB) isolates against <em>S.</em> Typhimurium towards human intestinal cells.<br><strong>Materials and Methods:</strong> 12 HK-LAB isolates from 3 sources of origin (stingless bee, plant, and food) were tested to determine the adhesion of HK-LAB to Caco-2 cells, anti-invasion and antibacterial activities against<em> S</em>. Typhimurium, the adhesion and invasion pattern of<em> S</em>. Typhimurium on intestinal epithelial cells (Caco-2) and assessing the effect of LAB on the S. Typhimurium-host cell interaction.<br><strong>Results:</strong> Tairu isolates from food have the highest adhesion rate with 19 ± 1.32/10 Caco-2 cells followed by HK-LAB R-isolate from plant 17 ± 0.70/10 Caco-2 cells, which is similar to the control (<em>Lactobacillus casei</em>). In the anti-invasion assay, the two HK-LAB isolates that had the strongest adherence to Caco-2 cells, Tairu-isolate inhibited at 78.1 ± 3.06% and R-isolate inhibited at 64.76 ± 9.02% compared to the positive control (63.81 ± 1.15%), which led to increased suppression of<em> S</em>. Typhimurium accordingly. Tairu and R isolates were tested for their antibacterial ability against <em>S.</em> Typhimurium. Both R and Tairu isolates displayed strong inhibition zones (27 ± 0.06 mm, 23 ± 0.06 mm) respectively.<br><strong>Conclusion:</strong> These findings suggest that the anti-invasion activities of HK-LAB R and Tairu may correlate to their bactericidal effects that serve to protect the host from infection.</p> 2024-12-08T10:05:51+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4347 Seroprevalence of Helicobacter pylori in a population of 15 to 35 years old in Mashhad 2024-12-21T09:33:06+0330 Mahdieh Khoshakhlagh Mahdiye.khgh@gmail.com Mohammadreza Tarahomi vandan6030@gmail.com Fatemeh Asgharian asgharianf951@mums.ac.ir Arghavan Kamali Arghavan1999km@gmail.com Safoora Sa'd Abadi safoora.sadabadi@gmail.com Kimia Jafarpour Jafarpourkimiya@gmail.com Samaneh Abolbashari s.abolbashari@gmail.com Mojtaba Meshkat m.meshkat@sbmu.ac.ir Aida Gholoobi aida.gholoobi@gmail.com <p><strong>Background and Objectives:</strong> <em>Helicobacter pylori (H. pylori)</em> is a bacterium involved in gastrointestinal disorders with a high prevalence in Iran. We have determined the seroprevalence of <em>H. pylori</em> in the young adult population of Mashhad city for the first time.<br><strong>Materials and Methods:</strong> We carried out a cross-sectional study on 933 individuals between the ages of 15 and 35 in Mashhad. The serum level of IgG, IgM, and IgA <em>H. pylori</em> antibodies was determined using enzyme linked immunosorbent assay (ELISA) method.<br><strong>Results:</strong> The average age of the participants including 290 (31.0%) male and 643 (68.9%) female cases was 25.47 ± 5.76. <em>H. pylori</em> IgG was seropositive in 365 (39.1%) of subjects. Occupation (p=0.002), body mass index (p=0.002), marital status (p&lt;0.0001), and age (p&lt;0.007) were meaningfully related to<em> H. pylori</em> IgG seropositivity. Other factors such as sex, educational attainment, history of chronic diseases, and smoking cigarette had no significant relationship with the presence of <em>H. pylori</em> antibodies.<br><strong>Conclusion:</strong> The seroprevalence of <em>H. pylori</em> IgG antibodies in Mashhad's 15 to 35 years old citizens was determined 39.1%. We suggest further studies with larger sample sizes and different age groups as the target population.</p> 2024-12-08T10:07:27+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4723 Efficacy of traditional herb aqua extract of Teucrium stocksianum and its fractions against HSV-1 virus expression levels of genes (UL46 and US6) 2024-12-21T09:33:10+0330 Emad Asgari emadasgari@ut.ac.ir Zohreh Sharifi z.sharifi@ibto.ir Farahnaz Bineshian m.zamanian@ibto.ir Mahsa Zamanian mahsa_emad@yahoo.com <p><strong>Background and Objectives:</strong> Recently, the anti-herpetic activities of different plant species have been investigated. This study evaluated the effects of <em>Teucrium stocksianum</em> aqueous extract on the HSV-1 virus-infected Vero cell.<br><strong>Materials and Methods:</strong> The IC<sub>50</sub> of the aqueous extract was obtained by the maceration of the plant in boiling water and has been measured with the MTT method, also the q-PCR was used to study viral gene expression reduction.<br><strong>Results:</strong> Results of the MTT test indicated that the highest percentage of metabolic activity was observed in the 75 μg/ml concentration of <em>Teucrium stocksianum</em>’s aqueous extracts (IC<sub>50</sub>=45.5μg/ml). Time intervals of 24 and 48 hours after viral infection revealed that the cell viability is reduced by the viral infection time (MOI=0.1), log 10<sup>-3</sup>, p &lt;0.001). Furthermore, the plant’s aqueous extract concentration almost avoids cell viability reduction. Through Q-PCR results; the reduction of viral proliferation revealed that the low expression of genes UL46 and US6 were significant in the presence of different treatments utilized in the experiment.<br><strong>Conclusion:</strong> <em>T. stocksianum</em>, has an anti-viral property and may be considered as a remedy for anti-HSV-1 agents.</p> 2024-12-08T10:09:08+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4559 Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro 2024-12-21T09:33:13+0330 Javad Charostad J.4ostad@gmail.com Tahere Navidfar roya_67@ymail.com Masoumeh Kiani m.kianii2018@gmail.com Paul Schinitzler paul.schnitzler@med.uni-heidelberg.de Akram Astani astani_ir@yahoo.com <p><strong>Background and Objectives:</strong> Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of <em>Ferula assa-feotida</em> against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir.<br><strong>Materials and Methods:</strong> In our experimental study, <em>Ferula assa-feotida</em> was dissolved in DMSO, then diluted in DMEM medium. Acyclovir was used at a concentration of 100 μM in all procedures. The antiherpetic activity and Antiviral activity of <em>Ferula</em> were evaluated in Vero cells (African green monkey kidney cells) by using the plaque reduction assay.<br><strong>Results:</strong> Inhibitory concentrations of 50% (IC<sub>50</sub>) of <em>Ferula assa-feotida</em> for HSV-1 and HSV-2 were determined at 0.00025% and 0.00015%, respectively. <em>Ferula</em> was introduced at various stages of viral infection and significantly inhibited HSV-1 and HSV-2 infectivity by &gt; 95.5% and 89%, respectively, when virus was pre-treated before addition to the cells. No HSV-1 or HSV-2 activity was detected in cells treated prior to and following viral infection.<br><strong>Conclusion:</strong> These results indicate that <em>Ferula assa-feotida</em> demonstrates antiherpetic activity in the early phase of viral infection and could be used as potential antiviral agent.</p> 2024-12-08T10:10:43+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4825 Distribution of fungal agents in the respiratory system of patients with underlying lung diseases; molecular identification and antifungal susceptibility profiles 2024-12-21T09:33:16+0330 Parviz Hassanpour parvizhassanpour@yahoo.com Seyed Jamal Hashemi sjhashemi@tums.ac.ir Sanam Nami sanamnami@yahoo.com Roshanak Daie Ghazvini rdaie@tums.ac.ir Behrouz Naghili Hokmabadi naghilyb@tbzmed.ac.ir Abbas Rahimi Foroushani rahimifo@tums.ac.ir Kazem Ahmadikia Kazem_Ahmadikia@yahoo.com Zahra Ramezanalipour z.ramezanalipour.1995@gmail.com Saeid Firouzi Abriz saeidfirouzi1982@gmail.com <p><strong>Background and Objectives:</strong> Airway fungal infection is a severe clinical problem, especially in patients with compromised immune functions. Here, we examined the distribution and antifungal susceptibility profiles of fungal agents isolated from respiratory tract of symptomatic patients hospitalized in pulmonary units.<br><strong>Materials and Methods:</strong> This descriptive cross-sectional study took place from 2023 to 2024, involving 360 patients. Bronchoalveolar lavage (BAL) or sputum specimens were collected and analyzed using mycological and molecular methods for this study. Antifungal susceptibility testing (AFST) was carried out using the broth micro dilution method.<br><strong>Results:</strong> Of a total of 360 respiratory specimens, 114 (31.6%) were positive. The male-to-female ratio was 63:51 (1.3%). <em>Candida albicans</em> and <em>Aspergillus flavus</em> were the most common yeast and mold species. Chronic obstructive pulmonary disease (COPD) had the highest rate of colonization with fungal agents (47/114, 41%). The isolates associated with COPD in this study included <em>Aspergillus</em> species (4/12, 3.5%), <em>Candida</em> species (41/96, 36%), and other fungal species (2/6, 1.5%). Coughing (87%) was the predominant symptom, and malignancy (52%) was the predominant comorbidity factor. The result of AFST for antifungal agents showed that 9 (22.5%) <em>Candida</em> isolates were resistant, and the highest rate of resistance was related to voriconazole agent (5/9, 55.5%). Resistance to antifungal agents was not observed among <em>Aspergillus</em> isolates.<br><strong>Conclusion: </strong>This study showed a significant relationship between the frequency of <em>Aspergillus</em> and <em>Candida</em> species in patients with underlying lung diseases. In addition, voriconazole was more effective than itraconazole, especially against <em>Aspergillus flavus.</em></p> 2024-12-08T10:12:37+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4919 Exploring oral candidiasis among cancer patients undergoing chemotherapy in eastern Iran 2024-12-21T09:33:21+0330 Abdol Sattar Pagheh Pagheh.as@gmail.com Fatemeh Kardan fateme.kardan93@gmail.com Aynaz Ghojoghi ayghojoghi@gmail.com Ahmad Reza Sebzari a_sebzari@yahoo.com Maryam Erfaninejad maryam.erfaninejad@yahoo.com Parvin Askari parvin.askari.90@gmail.com Seyed Reza Aghili satar_p2010@yahoo.com Eisa Nazar nezar.eisa@gmail.com Masood Ziaee dr.m.ziaee@gmail.com <p><strong>Background and Objectives:</strong> Understanding the epidemiology of <em>Candida</em> species among cancer patients is crucial for preventing invasive infections. This study aimed to identify <em>Candida</em> species and assess risk factors among cancer patients receiving chemotherapy in Birjand, eastern Iran.<br><strong>Materials and Methods:</strong> The samples were obtained from the oral cavity of 140 patients and the initial identification of <em>Candida</em> species was carried out through fungal cultures. Subsequently, <em>Candida</em> isolates were molecularly identified using the PCR-RFLP method with the restriction enzyme Msp1. Furthermore, the demographic characteristics, risk factors, and clinical history of the patients were extracted and scrutinized using a multiple logistic regression model.<br><strong>Results:</strong> Among the 140 patients examined, 55 individuals (39.3%) tested positive for oral candidiasis (OC). Notably, Hemorrhagic cancer emerged as the most common type of cancer associated with OC (46.7%). The predominant species isolated was the <em>Candida albicans</em> complex (64.8%), followed by the <em>Candida glabrata</em> complex (26.8%). A noteworthy finding was the significant association between the occurrence of OC and the number of chemotherapy sessions (P&lt;0.05). Conversely, no significant correlations were detected between OC and variables such as sex, age, type of cancer, occupation, residence, underlying disease, and drug use (P&gt;0.05).<br><strong>Conclusion:</strong> The prevalence of <em>Candida</em> spp. and its correlation with the number of chemotherapy sessions underscored the importance of preventive measures. These findings provided valuable insights for designing targeted interventions to mitigate the burden of oral candidiasis in this vulnerable population.</p> 2024-12-08T10:14:04+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4614 Evaluation of the potential of multi-trait PGPR isolates as inoculants for maize (Zea mays L.) growth 2024-12-21T09:33:26+0330 Ebrahim Eshaghi ebi.eshaghi55@gmail.com Sara Mousae s.mosae@gmail.com Ali Hendiyani hendiyani@gmail.com Alireza Habibi Khave iraniancollegian2@gmail.com Rahim Nosrati nosratirahim@gmail.com <p><strong>Background and Objectives:</strong> Plant growth-promoting rhizobacteria (PGPR) with a diverse set of traits can improve crop yield in agriculture. The current study aimed to evaluate the potential of multi-trait PGPR isolates as inoculants for maize (<em>Zea mays L.</em>) growth.<br><strong>Materials and Methods:</strong> In this study, 23 bacterial isolates were initially screened from maize plant rhizosphere. Ten isolates (A1–A10) were selected based on N fixation, P and K solubilization and their <em>in vitro</em> specific PGPR traits, such as solubilization of Zn, and Mn, the production of IAA, siderophore, ammonia, and HCN were assayed. Finally, the potential of selected isolates in enhancing the germination, height, shoot collar diameter, shoot fresh and dry weight biomass, and root dry weight of maize were evaluated.<br><strong>Results:</strong> Among the positive-PGPR colonies, the selected isolates demonstrated the better performance of PGPR traits such as highest nitrogen fixation, P, K, Mn, and Zn solubilization, and production of siderophore, HCN, NH3, and IAA. In addition, the maize seed germination and improvement of maize yield in a pot experiment were observed after their treatment by bacterial inoculants. Biochemical characteristics, 16S rDNA amplification, and sequencing demonstrated a high similarity of PGPR isolates to the strains of <em>Enterobacter, Pantoea, Kluyvera, Lelliottia, Klebsiella, Pectobacterium,</em> and <em>Stenotrophomonas</em>.<br><strong>Conclusion:</strong> The findings demonstrated that these strains could prove effective PGPR inoculants for the improvement of maize crops as multiple bio-fertilizers.</p> 2024-12-08T10:15:58+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4969 Comparison of the synthesis of the alpha-amylase enzyme by the native strain Bacillus licheniformis in immobilized and immersed cells 2024-12-21T09:33:30+0330 Fahimeh Mahmoudnia f.mahmoudnia@cfu.ac.ir <p><strong>Background and Objectives:</strong> The study focused on the amylase enzyme, widely used in the industrial starch liquefaction process. We looked into the best way to immobilize the native strain <em>Bacillus licheniformis</em>, which is the only alpha-amylase-producing bacterium, by trapping it in calcium alginate gel. This is a promising way to increase enzyme output.<br><strong>Materials and Methods:</strong> We examined the effects of alginate content, biomass age, initial cell loading (ICL), bead size, and solidification duration in calcium chloride solution on enzyme synthesis. We conducted batch fermentations using both immobilized and free cells.<br><strong>Results:</strong> Alpha-amylase production significantly increased with the alginate concentration ratio, achieving a maximum enzyme yield of 23.5 U/mL at a 30 g/l alginate concentration, utilizing an initial cell loading of 1.5 g in 150-200 beads per flask. These involved cells from a 12-hour culture with a bead size of 5.0 mm, were solidified for 24 hours in a 2.5% (w/v) calcium chloride solution. The yield of the immobilized cells was approximately 111.71% higher than that of the free cells, which produced 11.1 U/ml. The immobilized cells consistently generated alpha-amylase over five repeated cycles, attaining a peak value of 23.5 U/ml during the first cycle, which was 2.2-fold more than the control (free cells).<br><strong>Conclusion:</strong> We used a basic mass balance analysis to understand the growth of both fractions and the dynamics of amylase production in free cells and cells immobilized in Ca-alginate beads. The production of alpha-amylase in immobilized cells results in enhanced volumetric activities during fermentation. Notable advantages of this technique encompass prolonged stability, reuse and recycling, and the potential for adaptable regeneration.</p> 2024-12-08T10:17:33+0330 ##submission.copyrightStatement## https://ijm.tums.ac.ir/index.php/ijm/article/view/4831 The microbiology, epidemiology, risk factors, and clinical therapy of candidemia in burn patients hospitalized in Velayat Teaching Hospital, Rasht, northern Iran 2024-12-21T09:33:33+0330 Zahra Rafat rafat.zahra2015@gmail.com Davoud Roostaei droostaei@gmail.com Mohammadreza Mobayen maziar.mobayen@gmail.com Hamid Salehiniya alesaleh70@yahoo.com Parimah Pournasrolah pn.parimah@yahoo.com <p><strong>Background and Objectives:</strong> The study aimed to investigate the epidemiology and clinical therapy of candidemia in burn patients hospitalized in Velayat Hospital, Rasht, Iran.<br><strong>Materials and Methods:</strong> The blood samples of suspected patients were cultured and PCR-sequencing was performed. Antifungal susceptibility testing was done by the CLSI M27-A4 document.<br><strong>Results:</strong> Four blood samples were identified as positive. <em>Candida parapsilosis</em> complex (3 out of 4, 75%) was the predominant leading cause of candidemia. MIC values showed that all isolates were susceptible to itraconazole, amphotericin B, and 5-flucytosine.<br><strong>Conclusion:</strong> It seems necessary to pay attention to <em>Candida</em> non-<em>albicans</em> species in antifungal therapy.</p> 2024-12-08T10:19:17+0330 ##submission.copyrightStatement##